RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
US based company with European based operations seeks channel partners to expand marketing and distribution of its information management software products that are designed and developed for blood banks, transfusion centres, hospitals, laboratories, etc More
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
Lotuzol is a new herbal drug composing water extract powder of Nelumbinis Semen to treat depression without sexual dysfunction, a major adverse effect in commonly used anti-depressants. More
Dendritic cell (DC) generation and manipulation technology for the development of a cancer vaccine and rheumatoid arthritis (RA) therapeutics. Based on DC manipulating technology, Creagene is developing DC-based cancer vaccines against renal cell car More
We have technology to produce chiral intermediates of high quality by biotransformation More
Planning and delivery of TDS facilities with our SPECIAL KNIFE COATER TECHNOLOGY More
A series of SynLeptin peptides, particularly, SynLeptin-2 shows remarkable anti-obesity activities which were verified in animal experiments using mice and rabbits. More
Planning and delivery of TDS facilities with TDS - MODULAR COATING MACHINES More
Device that provides nurses or other health care workers with protection against accidental needle sticks More
Displaying 1..10 of 15 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2010 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us